ArticleJournal of the National Cancer Institute2025

Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.

Lindsey Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.